questionsmedicales.fr
Disciplines et activités comportementales
Psychothérapie
Thérapie comportementale
Thérapie comportementale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale : Questions médicales les plus fréquentes",
"headline": "Thérapie comportementale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie comportementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Psychothérapie",
"url": "https://questionsmedicales.fr/mesh/D011613",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie de maitrise de la colère",
"alternateName": "Anger Management Therapy",
"url": "https://questionsmedicales.fr/mesh/D000067449",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie de maitrise de la colère",
"code": {
"@type": "MedicalCode",
"code": "D000067449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.087"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Analyse comportementale appliquée",
"alternateName": "Applied Behavior Analysis",
"url": "https://questionsmedicales.fr/mesh/D000072357",
"about": {
"@type": "MedicalCondition",
"name": "Analyse comportementale appliquée",
"code": {
"@type": "MedicalCode",
"code": "D000072357",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.131"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie aversive",
"alternateName": "Aversive Therapy",
"url": "https://questionsmedicales.fr/mesh/D001348",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie aversive",
"code": {
"@type": "MedicalCode",
"code": "D001348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.174"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie cognitive",
"alternateName": "Cognitive Behavioral Therapy",
"url": "https://questionsmedicales.fr/mesh/D015928",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie cognitive",
"code": {
"@type": "MedicalCode",
"code": "D015928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie d'acceptation et d'engagement",
"alternateName": "Acceptance and Commitment Therapy",
"url": "https://questionsmedicales.fr/mesh/D064869",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie d'acceptation et d'engagement",
"code": {
"@type": "MedicalCode",
"code": "D064869",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Restructuration cognitive",
"alternateName": "Cognitive Restructuring",
"url": "https://questionsmedicales.fr/mesh/D000088686",
"about": {
"@type": "MedicalCondition",
"name": "Restructuration cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000088686",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pleine conscience",
"alternateName": "Mindfulness",
"url": "https://questionsmedicales.fr/mesh/D064866",
"about": {
"@type": "MedicalCondition",
"name": "Pleine conscience",
"code": {
"@type": "MedicalCode",
"code": "D064866",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Remédiation cognitive",
"alternateName": "Cognitive Remediation",
"url": "https://questionsmedicales.fr/mesh/D000072466",
"about": {
"@type": "MedicalCondition",
"name": "Remédiation cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000072466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.365"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Désensibilisation psychologique",
"alternateName": "Desensitization, Psychologic",
"url": "https://questionsmedicales.fr/mesh/D003887",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation psychologique",
"code": {
"@type": "MedicalCode",
"code": "D003887",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"alternateName": "Eye Movement Desensitization Reprocessing",
"url": "https://questionsmedicales.fr/mesh/D057169",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"code": {
"@type": "MedicalCode",
"code": "D057169",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie implosive",
"alternateName": "Implosive Therapy",
"url": "https://questionsmedicales.fr/mesh/D007171",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie implosive",
"code": {
"@type": "MedicalCode",
"code": "D007171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.325"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par réalité virtuelle",
"alternateName": "Virtual Reality Exposure Therapy",
"url": "https://questionsmedicales.fr/mesh/D063367",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par réalité virtuelle",
"code": {
"@type": "MedicalCode",
"code": "D063367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.662"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale dialectique",
"alternateName": "Dialectical Behavior Therapy",
"url": "https://questionsmedicales.fr/mesh/D000077252",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale dialectique",
"code": {
"@type": "MedicalCode",
"code": "D000077252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.628"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par la relaxation",
"alternateName": "Relaxation Therapy",
"url": "https://questionsmedicales.fr/mesh/D012064",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par la relaxation",
"code": {
"@type": "MedicalCode",
"code": "D012064",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méditation",
"alternateName": "Meditation",
"url": "https://questionsmedicales.fr/mesh/D019122",
"about": {
"@type": "MedicalCondition",
"name": "Méditation",
"code": {
"@type": "MedicalCode",
"code": "D019122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chronothérapie sur les phases de sommeil",
"alternateName": "Sleep Phase Chronotherapy",
"url": "https://questionsmedicales.fr/mesh/D055865",
"about": {
"@type": "MedicalCondition",
"name": "Chronothérapie sur les phases de sommeil",
"code": {
"@type": "MedicalCode",
"code": "D055865",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale",
"alternateName": "Behavior Therapy",
"code": {
"@type": "MedicalCode",
"code": "D001521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Daniel F Gros",
"url": "https://questionsmedicales.fr/author/Daniel%20F%20Gros",
"affiliation": {
"@type": "Organization",
"name": "Mental Health Service, Ralph H. Johnson VA Healthcare System, Charleston, South Carolina, USA."
}
},
{
"@type": "Person",
"name": "Tanja van der Zweerde",
"url": "https://questionsmedicales.fr/author/Tanja%20van%20der%20Zweerde",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands. Electronic address: t.vander.zweerde@vu.nl."
}
},
{
"@type": "Person",
"name": "Jaap Lancee",
"url": "https://questionsmedicales.fr/author/Jaap%20Lancee",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, University of Amsterdam, Nieuwe Achtergracht 129, Amsterdam 1018 WS, the Netherlands; PsyQ Amsterdam, Amsterdam, the Netherlands."
}
},
{
"@type": "Person",
"name": "Annemieke van Straten",
"url": "https://questionsmedicales.fr/author/Annemieke%20van%20Straten",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands."
}
},
{
"@type": "Person",
"name": "Shireen L Rizvi",
"url": "https://questionsmedicales.fr/author/Shireen%20L%20Rizvi",
"affiliation": {
"@type": "Organization",
"name": "Rutgers University. Electronic address: slrizvi@gsapp.rutgers.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Machine-Identified Patterns of Visual Field Loss and an Association with Rapid Progression in the Ocular Hypertension Treatment Study.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35817199",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ophtha.2022.07.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of baseline optical coherence tomography angiography with the development of glaucomatous visual field defects in preperimetric glaucoma eyes.",
"datePublished": "2022-08-05",
"url": "https://questionsmedicales.fr/article/37863500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bjo-2021-321025"
}
},
{
"@type": "ScholarlyArticle",
"name": "Frequency of Visual Fields Needed to Detect Glaucoma Progression: A Computer Simulation Using Linear Mixed Effects Model.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/37054400",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/IJG.0000000000002155"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigating the linkage between mesopic spatial summation and variations in retinal ganglion cell density across the central visual field.",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37118942",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/opo.13158"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optical coherence tomography detects early optic nerve damage before visual field defect in patients with pituitary tumors.",
"datePublished": "2023-04-14",
"url": "https://questionsmedicales.fr/article/37058150",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10143-023-01990-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie comportementale",
"item": "https://questionsmedicales.fr/mesh/D001521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie comportementale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie comportementale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie comportementale",
"description": "Comment diagnostiquer un besoin de thérapie comportementale ?\nQuels tests sont utilisés pour le diagnostic ?\nQui peut poser un diagnostic pour cette thérapie ?\nQuels critères sont utilisés pour le diagnostic ?\nLa thérapie comportementale est-elle adaptée à tous ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie comportementale",
"description": "Quels symptômes indiquent un besoin de thérapie comportementale ?\nComment les symptômes varient-ils selon les individus ?\nLes symptômes physiques sont-ils liés à la thérapie comportementale ?\nLes symptômes peuvent-ils s'aggraver sans traitement ?\nQuels sont les signes d'amélioration avec la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie comportementale",
"description": "Comment prévenir les troubles nécessitant une thérapie comportementale ?\nLes programmes scolaires peuvent-ils aider à la prévention ?\nQuels rôles jouent les parents dans la prévention ?\nLa prévention est-elle possible à l'âge adulte ?\nLes groupes de soutien peuvent-ils aider à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie comportementale",
"description": "Quelles techniques sont utilisées en thérapie comportementale ?\nCombien de séances sont généralement nécessaires ?\nLa thérapie comportementale peut-elle être combinée avec d'autres traitements ?\nQuels sont les objectifs principaux de cette thérapie ?\nLa thérapie comportementale est-elle efficace pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie comportementale",
"description": "Quelles complications peuvent survenir sans traitement ?\nLa thérapie comportementale peut-elle entraîner des effets secondaires ?\nQuels risques de rechute existent après la thérapie ?\nLes complications psychologiques peuvent-elles affecter la santé physique ?\nComment minimiser les complications après la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie comportementale",
"description": "Quels facteurs augmentent le risque de troubles comportementaux ?\nL'environnement familial influence-t-il les comportements ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe manque de soutien social est-il un facteur de risque ?\nLes événements de vie stressants augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de thérapie comportementale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel évalue les comportements problématiques et leur impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des entretiens cliniques sont souvent utilisés pour évaluer les comportements."
}
},
{
"@type": "Question",
"name": "Qui peut poser un diagnostic pour cette thérapie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un psychologue, un psychiatre ou un thérapeute qualifié peut poser ce diagnostic."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, l'intensité et l'impact des comportements sur la vie."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle adaptée à tous ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est efficace pour de nombreux troubles, mais un diagnostic précis est essentiel."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de thérapie comportementale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements compulsifs, des phobies ou des troubles d'anxiété peuvent indiquer ce besoin."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en intensité et en type selon les expériences personnelles."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques sont-ils liés à la thérapie comportementale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes physiques comme des palpitations peuvent accompagner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver sans traitement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'intensifier et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'amélioration avec la thérapie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réduction des comportements problématiques et une meilleure gestion des émotions sont des signes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles nécessitant une thérapie comportementale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation émotionnelle et le développement de compétences sociales dès le jeune âge."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des programmes de sensibilisation et de gestion des émotions dans les écoles peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les parents dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les parents peuvent enseigner des stratégies de gestion du stress et des comportements positifs à leurs enfants."
}
},
{
"@type": "Question",
"name": "La prévention est-elle possible à l'âge adulte ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques de gestion du stress et de résolution de problèmes peuvent prévenir l'apparition de troubles."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien peuvent-ils aider à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un espace pour partager des expériences et apprendre des stratégies de prévention."
}
},
{
"@type": "Question",
"name": "Quelles techniques sont utilisées en thérapie comportementale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme le conditionnement opérant, l'exposition et la restructuration cognitive sont courantes."
}
},
{
"@type": "Question",
"name": "Combien de séances sont généralement nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie, mais 10 à 20 séances sont souvent recommandées pour des résultats significatifs."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle être combinée avec d'autres traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent combinée avec des médicaments ou d'autres formes de thérapie pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Quels sont les objectifs principaux de cette thérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les objectifs incluent la modification des comportements inadaptés et l'amélioration des compétences d'adaptation."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle efficace pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent utilisée pour traiter des troubles chez les enfants, comme l'anxiété et les phobies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, les troubles peuvent s'aggraver, entraînant des problèmes relationnels et professionnels."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle entraîner des effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, elle n'a pas d'effets secondaires physiques, mais des émotions intenses peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques de rechute existent après la thérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rechutes peuvent survenir si les compétences acquises ne sont pas pratiquées régulièrement."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques peuvent-elles affecter la santé physique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques non traités peuvent entraîner des problèmes de santé physique, comme des maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications après la thérapie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pratique continue des compétences apprises et le soutien social aident à minimiser les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles comportementaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le stress, l'hérédité et des événements traumatiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'environnement familial influence-t-il les comportements ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement familial instable ou conflictuel peut contribuer au développement de troubles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles mentaux dans la famille peuvent augmenter le risque de troubles comportementaux."
}
},
{
"@type": "Question",
"name": "Le manque de soutien social est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque de soutien social peut exacerber les troubles et rendre la gestion plus difficile."
}
},
{
"@type": "Question",
"name": "Les événements de vie stressants augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des événements comme un divorce ou la perte d'un emploi peuvent déclencher des troubles comportementaux."
}
}
]
}
]
}
To identify patterns of visual field (VF) loss based on unsupervised machine learning and to identify patterns that are associated with rapid progression....
Cross-sectional and longitudinal study....
A total of 2231 abnormal VFs from 205 eyes of 176 Ocular Hypertension Treatment Study (OHTS) participants followed over approximately 16 years....
Visual fields were assessed by an unsupervised deep archetypal analysis algorithm and an OHTS-certified VF reader to identify prevalent patterns of VF loss. Machine-identified patterns of glaucoma dam...
Machine-expert correspondence and type of patterns of VF loss associated with rapid progression....
The average VF mean deviation (MD) at conversion to glaucoma was -2.7 decibels (dB) (standard deviation [SD] = 2.4 dB), whereas the average MD of the eyes at the last visit was -5.2 dB (SD = 5.5 dB). ...
An automated machine learning system can identify patterns of VF loss and could provide objective and reproducible nomenclature for characterizing early signs of visual defects and rapid progression i...
To evaluate whether baseline vessel density (VD) parameters derived from optical coherence tomography angiography (OCT-A) is associated with the development of glaucomatous visual field (VF) defects i...
One eye from each of 200 consecutive PPG patients with a normal standard automated perimetry and OCT-A at baseline was retrospectively analysed. OCT-A was used to measure the circumpapillary VD (cpVD)...
During a 3.1-year average follow-up period, 18 eyes (9.0%) developed glaucomatous VF defects. At baseline, the lower inferior temporal cpVD (HR (95% CI)=0.934 (0.883 to 0.988); p=0.017) and thinner in...
In PPG eyes, a lower baseline inferior temporal cpVD is significantly associated with glaucomatous VF defect development and a faster rate of global VF loss....
Irregular visual field test frequency at relatively short intervals initially and longer intervals later on in the disease provided acceptable results in detecting glaucoma progression....
It is challenging to maintain a balance between the frequency of visual field testing and the long-term costs that may result from insufficient treatment of glaucoma patients. This study aims to simul...
An LMM with random intercept and slope was used to simulate the series of mean deviation sensitivities over time. A cohort study including 277 glaucoma eyes that were followed for 9.0±1.2 years was us...
By doing one confirmatory test, the percentage of incorrect progression detection decreased considerably. The time to detect progression was shorter for eyes with an evenly spaced 4-monthly schedule, ...
Irregular visual field test frequency at relatively short intervals initially and longer intervals later on in the disease provided acceptable results in detecting glaucoma progression. This approach ...
The relationship between perimetric stimulus area and Ricco's area (RA) determines measured thresholds and the sensitivity of perimetry to retinal disease. The nature of this relationship, in addition...
Achromatic luminance thresholds were measured for six incremental spot stimuli (0.009-2.07 deg...
Ricco's area exhibited a small but statistically insignificant increase between 2.5° and 10° eccentricity. Compared with photopic conditions, RA was larger, with the difference between RA and the Gold...
Ricco's area and the number of RGCs underlying RA do not vary significantly across the central visual field in mesopic conditions. However, RA is larger and more similar to the standard perimetric Gol...
Optical coherence tomography (OCT) is a useful tool for predicting visual recovery after the removal of pituitary tumors. However, the utility of OCT in patients with pituitary tumors and a normal vis...
This study aimed to predict future visual field tests using a bidirectional gated recurrent unit (Bi-GRU) and assess its performance based on the number of input visual field tests and the prediction ...
This study included patients who underwent visual field tests at least four times at five university hospitals between June 2004 and April 2022. All data were accessed in October 2022 for research pur...
The prediction errors of the Bi-GRU model for MD, PSD, VFI, and TDV ranged from 1.20 to 1.68 dB, 0.95 to 1.16 dB, 3.64 to 4.51%, and 2.13 to 2.60 dB, respectively, depending on the number of input vis...
In clinical practice, the Bi-GRU model can predict future visual field tests at the desired time points using three or more previous visual field tests....
To use longitudinal optical coherence tomography (OCT) and OCT angiography (OCTA) data to detect glaucomatous visual field (VF) progression with a supervised machine learning approach....
Prospective cohort study....
One hundred ten eyes of patients with suspected glaucoma (33.6%) and patients with glaucoma (66.4%) with a minimum of 5 24-2 VF tests and 3 optic nerve head and macula images over an average follow-up...
VF progression was detected in 28 eyes (25.5%). The model with combined baseline and longitudinal OCT and OCTA parameters at the global and hemifield levels had the best classification accuracy to det...
Longitudinal OCTA measurements complement OCT-derived structural metrics for the evaluation of functional VF loss in patients with glaucoma....
The aim of this study was to investigate the associations between fluctuation in blood pressure (BP), ocular perfusion pressure (OPP) and visual field (VF) progression in normal-tension glaucoma (NTG)...
This prospective, longitudinal study included 44 patients with NTG. Only newly diagnosed NTG patients who had not been treated with a glaucoma medication were included. Patients were examined every ye...
After 7 years of follow-up, 9 of the 44 patients showed VF progression. The standard deviation (SD) of SBP and OPP were significantly associated with VF progression (P = 0.007, < 0.001, respectively)....
Fluctuation in OPP was associated with VF progression in patients with NTG....
To study the associations between optic nerve head (ONH) strains under intraocular pressure (IOP) elevation with retinal sensitivity in patients with glaucoma....
Clinic-based cross-sectional study....
Two hundred twenty-nine patients with primary open-angle glaucoma (subdivided into 115 patients with high-tension glaucoma [HTG] and 114 patients with normal-tension glaucoma [NTG])....
For 1 eye of each patient, we imaged the ONH using spectral-domain OCT under the following conditions: (1) primary gaze and (2) primary gaze with acute IOP elevation (to approximately 35 mmHg) achieve...
Associations between ONH strains and values of retinal sensitivity from visual field testing....
For patients with HTG, we found (1) significant negative linear associations between ONH strains and retinal sensitivity (P < 0.001; on average, a 1% increase in ONH strains corresponded to a decrease...
We found significant negative associations between IOP-induced ONH strains and retinal sensitivity in a relatively large glaucoma cohort. Specifically, patients with HTG who experienced higher ONH str...
To evaluate the correlations between relative afferent pupillary defect (RAPD) magnitude, assessed using the clinical plus scale and neutral density filters, and visual field parameters in patients wi...
Fifty-two patients with RAPD, graded by the swinging flashlight test and neutral density filters, were analyzed in this cross-sectional trial. The RAPD clinical plus scale was divided into grade 1+, i...
RAPD clinical plus grades were correlated with interocular VFI (r = 0.55, P < 0.001) and MD (r = 0.48, P = 0.004) differences. Average interocular VFI differences were estimated as follows: 16.75 × RA...
The RAPD plus scale and neutral density filter grading systems were associated with quantitative visual field defect parameters, with VFI showing the strongest association. RAPD clinical grading could...